Mariners face tough free agency decisions after ALCS loss, with key players Naylor and Suárez potentially departing and the team eyeing Japanese slugger Murakami as a replacement.
Investor Tom Hulick highlights Broadcom's AI-focused, power-efficient ASICs and Eli Lilly's GLP-1 drug pipeline, while StockStory cautions against uncritical acceptance of Wall Street price targets.
Cy Young winner Tarik Skubal's massive contract demands have sparked trade interest, with the Tigers facing a tough decision on retaining their ace or dealing him for substantial assets.
Mariners face tough free agency decisions after ALCS loss, with key players Naylor and Suárez potentially departing and the team eyeing Japanese slugger Murakami as a replacement.
Investor Tom Hulick highlights Broadcom's AI-focused, power-efficient ASICs and Eli Lilly's GLP-1 drug pipeline, while StockStory cautions against uncritical acceptance of Wall Street price targets.
Cy Young winner Tarik Skubal's massive contract demands have sparked trade interest, with the Tigers facing a tough decision on retaining their ace or dealing him for substantial assets.